Description
Transdermal and Transmucosal Drug Delivery Markets
Transdermal and Transmucosal Drug Delivery Markets analyzes the current and potential markets for transdermal/transmucosal drug delivery, a well-established accepted route of administration for therapeutically beneficial medicines.
Transdermal and Transmucosal Drug Delivery Markets provides the following market information:
- The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals, 2013-2020
- The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Systems by Type, 2013–2020
- The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies, Market Share by Type, 2013-2020
- Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015 (Smoking Cessation, Pain Management, Hormone, Cardio, Others)
- The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020 (United States, Europe, Japan, Rest of World, Global Market)
- The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2013-2020
- Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
The transdermal/transmucosal drug delivery market consists of many companies including large and small pharmaceutical companies as well as large and small drug delivery companies. The competition among participants is intensifying not only within the specific category such as transdermal drug delivery but also among the competing drug delivery technologies to provide the best possible vehicle for administration of a particular pharmaceutical product.
The report profiles companies involved in the transdermal/transmucosal drug delivery market. Drug delivery companies have made tremendous strides in the transdermal/transmucosal drug delivery market. Several companies have products that are already enjoying market success while many others are at various stages of development. There is little doubt that this area of drug delivery will continue to flourish in the coming years.
Challenges remain for the development of transdermal/transmucosal drug delivery systems but continued research will likely break down the barriers that limit the types of drug molecules that may be delivered through the skin. The market is expected to be driven by various factors including the loss of patent protection for blockbuster drugs and the need to avoid the first pass effects of oral drug delivery. Additionally, with an added focus on active transdermal technologies, new applications will likely cause a resurgence of interest in transdermal delivery of products.
Table of Contents
ONE: EXECUTIVE SUMMARY
Market Drivers
Market Size and Growth
Total Transdermal/Transmucosal Drug Delivery Market
Transdermal/Transmucosal Drug Delivery Only Market
Competitive and Market Analysis
TWO: INTRODUCTION AND OVERVIEW
Scope and Methodology
Reasons for Transdermal/Transmucosal Drug Delivery Systems
Phases of Drug Action
Transdermal Drug Delivery
History of Transdermal Drug Delivery
Advantages of Transdermal Drug Delivery
Disadvantages of Transdermal Drug Delivery
Passive Transdermal Drug Delivery
Transfersomes
Medicated Tattoos
Crystal Reservoir Technology
Active Transdermal Drug Delivery
Transdermal Microneedle Drug Delivery
Electrotransport Drug Delivery
Iontophoresis
Sonophoresis
Magnetophoresis
Photomechanical Waves
Transmucosal Drug Delivery
Buccal Drug Delivery
Vaginal Drug Delivery
THREE: TRENDS AND DEVELOPMENTS
Novel Transdermal Approvals
Innovations in Transdermal Drug Delivery
Adhesive Technology and Issues
Adhesive Market Issues
Generic Transdermal Study Design Guidelines
Biotechnological Issues
Developments in Insulin Delivery
New Developments in Hormone Drug Delivery
New Mucosal/Buccal Delivery Systems
Other Drug Delivery Systems
Microneedle-Assisted Transdermal Drug Delivery
Controlled Thermal Energy Technology
New Ultrasound Technology
Transdermal Products in Development
FOUR: MARKET SIZE AND GROWTH
The Total Transdermal/Transmucosal Drug Delivery Market
Transdermal Subsegment Market
Transdermal/Transmucosal Market by Application
MARKET ANALYSIS BY REGION
Transdermal/Transmucosal Delivery Technology Only Market
FIVE: COMPETITIVE ANALYSIS
Competitive Landscape
Emerging Participants
Market Analysis
SIX: COMPANY PROFILES
3M Pharmaceuticals
Acrux Limited
ALZA Corporation
Antares Pharma, Inc.
Apricus BioSciences, Inc
Aveva Drug Delivery Systems
Corium International, Inc
DURECT Corporation
Generex Biotechnology Corporation
Inovio Pharmaceuticals, Inc.
Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
MedPharm LTD
Mylan, Inc.
Nemaura Pharma Ltd
Nitto Denko Corporation
Noven Pharmaceuticals, Inc.
Pantec Biosolutions AG
Tapemark
tesa Labtec GmbH
TEVA Pharmaceutical Industries Ltd.
Zosano Pharma
APPENDIX: COMPANY DIRECTORY
TABLE OF EXHIBITS
TWO: INTRODUCTION AND OVERVIEW
Table 2-1
Sequence of Drug Action
Table 2-2
Select Leading Transdermal Delivery-Based Products
THREE: TRENDS AND DEVELOPMENTS
Table 3-1
Selected Transdermal Products in Development
FOUR: MARKET SIZE AND GROWTH
Table 4-1
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and
Pharmaceuticals, 2013-2020
Figure 4-1
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and
Pharmaceuticals, 2013-2020
Table 4-2
The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug
Delivery Systems by Type, 2013–2020
Figure 4-2
The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug
Delivery Systems, Revenues by Type, 2013–2020
Table 4-3
The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug
Delivery Technologies, Market Share by Type, 2013-2020
Figure 4-3
The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug
Delivery Technologies by Type, 2015
Figure 4-4
The Worldwide Market for Pharmaceuticals Utilizing Transdermal/Transmucosal Drug Delivery Technologies by Type, 2020
Table 4-4
The Worldwide Market for Transdermal Drug Delivery Systems by Type,
2013–2020
Figure 4-6
The Worldwide Market for Pharmaceuticals Utilizing Transdermal Drug Delivery
Systems, Revenues by Type, 2013–2020 (Passive, Active)
Figure 4-7
Transdermal/Transmucosal Drug Delivery by Indication by Percent, 2015(Smoking Cessation, Pain Management, Hormone, Cardio, Others)
Table 4-5
The Transdermal/Transmucosal Drug Delivery Market by Region, 2013-2020(United States, Europe, Japan, Rest of World, Global Market)
Figure 4-8
The Worldwide Transdermal/Transmucosal Drug Delivery Market by Region,2013-2020 (United States, Europe, Japan, Rest of World)
Figure 4-9
The Worldwide Transdermal/Transmucosal Drug Delivery Market, Distribution of Sales by Region, 2015 (United States, Europe, Japan, Rest of World)
Table 4-6
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 2013-2020
Table 4-7
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems,
Distribution of Revenue by Pharmaceutical and Drug Delivery Component,2013-2020
Figure 4-10
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems,
Distribution of Revenue by Pharmaceutical and Drug Delivery Component,2013-2020 (Drug Delivery Technology Revenues; Pharmaceutical Revenues,Utilizing Drug Delivery Technology)
Figure 4-11
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems,
Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2015(Drug Delivery Technology Revenues; Pharmaceutical Revenues, Utilizing Drug Delivery Technology)
Figure 4-12
The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems,
Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2020(Drug Delivery Technology Revenues; Pharmaceutical Revenues, Utilizing Drug Delivery Technology)
FIVE: COMPETITIVE ANALYSIS
Table 5-1
Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
